Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 23, 2026

Apr. 23, 2026

Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook

GlobeNewswire

Apr. 23, 2026

Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Apr. 23, 2026

Denta Biome Under Investigation: Adem Naturals Chewable Dental Tablets for Oral Health Care Support

GlobeNewswire

Apr. 23, 2026

SkinnyRx GLP-1 Claims Evaluated: Review Semaglutide & Tirzepatide Weight Loss Medication Options with Clinician-Guided Care

GlobeNewswire

Apr. 23, 2026

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

GlobeNewswire

Apr. 23, 2026

Chemed Reports First-Quarter 2026 Results

GlobeNewswire

Apr. 23, 2026

AVITA Medical to Announce First Quarter 2026 Financial Results

GlobeNewswire

Apr. 23, 2026

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Apr. 23, 2026

Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

GlobeNewswire

Apr. 23, 2026

Trevi Therapeutics to Participate in Upcoming May Events

GlobeNewswire

Apr. 23, 2026

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

GlobeNewswire

Apr. 23, 2026

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer

GlobeNewswire

Apr. 23, 2026

Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

GlobeNewswire

Apr. 23, 2026

iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule

GlobeNewswire

Apr. 23, 2026

Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

GlobeNewswire

Apr. 23, 2026

Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

GlobeNewswire

Apr. 23, 2026

Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors

GlobeNewswire

Apr. 23, 2026

The ROOT Brands Earns National Recognition for Patent‑Driven Wellness Innovation and Science‑Backed Consumer Products

GlobeNewswire

Apr. 23, 2026

Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.

GlobeNewswire

Apr. 23, 2026

This Alcohol Awareness Month, Oxford Treatment Center Raises Red Flag, Citing Significant Rise in Patients Seeking Help for Alcohol Addiction

GlobeNewswire